Safety and efficacy of ABBV-706, a seizure-related homolog protein 6 (SEZ6)-targeting antibody-drug conjugate, in high-grade neuroendocrine neoplasms Meeting Abstract
| Authors: | Cooper, A. J.; Chandana, S. R.; Furqan, M.; Papadopoulos, K. P.; Dowlati, A.; Han, J. Y.; Michael, M.; Cho, B. C.; Garmezy, B.; Kim, T. M.; Chiang, A. C.; Bar, J.; Choudhury, N. J.; Akerley, W. L.; Babu, S.; Munasinghe, W.; Robinson, R.; Kohlhapp, F.; Hingorani, P.; Byers, L. A. |
| Abstract Title: | Safety and efficacy of ABBV-706, a seizure-related homolog protein 6 (SEZ6)-targeting antibody-drug conjugate, in high-grade neuroendocrine neoplasms |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | 105 |
| Language: | English |
| ACCESSION: | WOS:001509267700001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.105 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 105 -- Source: Wos |
